Atom Investors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Atom Investors's IBB Position: Q4 2025 in Review
Atom Investors sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 33,539 shares — an estimated $4.84M sold.
Atom Investors first reported a position in IBB in Q1 2021 and held it in 19 quarters. The position peaked at $38.2M in Q4 2021. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.
- Atom Investors reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
- Atom Investors sold 33,539 iShares Biotechnology ETF shares in Q4 2025, an estimated $4.84M.
- Atom Investors first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 19 quarters.
- Atom Investors's iShares Biotechnology ETF position peaked at $38.2M in Q4 2021.
- 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.
Based on Atom Investors's 13F filing for Q4 2025, filed 17 Feb 2026.